Clinical Trial

Italian Real-life obServational Study on the effecTiveness, sAfety and Tolerability of Atogepant in Migraine Patients

Study acronym: STAR
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this prospective and multicentric study is to evaluate the effectiveness and tolerability of atogepant as preventive migraine treatment in a cohort of episodic or chronic migraine patients.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-05-10.
Status change: Recruiting → Active, Not Recruiting 2026-01-19
Trial Details
NCT Number NCT06414044
Lead Sponsor University of Florence
Collaborators: Fondazione Policlinico Universitario Campus Bio-Medico, IRCCS National Neurological Institute "C. Mondino" Foundation, Società Italiana per lo Studio delle Cefalee, Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari, Università degli Studi dell'Aquila, University of Roma La Sapienza, Azienda Ospedaliero Universitaria Policlinico Modena, Euganea Health Unit, Padua, Italy, Azienda Ospedaliero-Universitaria di Parma, Azienda Ospedaliera S. Maria della Misericordia, A.O.U. Città della Salute e della Scienza, Cliniche Humanitas Gavazzeni, University of Campania Luigi Vanvitelli, Ospedale Santo Stefano, Azienda Policlinico Umberto I, Auxologico San Luca, Asst Degli Spedali Civili Di Brescia
Conditions Migraine, Migraine With Aura, Migraine Without Aura, Chronic Migraine
Enrollment 500 participants
Start Date 2024-05-09
Primary Completion 2025-11-30 (estimated)
Study Completion 2026-04 (estimated)
Updated on ClinicalTrials.gov 2026-01-21